checkAd

     206  0 Kommentare Baudax Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Seite 3

    CONTACT: 
      
    Investor Relations Contact:
    Argot Partners
    Sam Martin / Claudia Styslinger
    (212) 600-1902
    sam@argotpartners.com
    claudia@argotpartners.com

    Baudax Bio, Inc.
    Ryan D. Lake
    (484) 395-2436
    rlake@baudaxbio.com

    Lesen Sie auch

    Media Contact:
    Argot Partners
    David Rosen
    (212) 600-1902
    david.rosen@argotpartners.com



    globenewswire
    0 Follower
    Autor folgen
    RSS-Feed abonnieren

    Weitere Artikel des Autors

    Seite 3 von 3

    Verfasst von globenewswire
    1 im Artikel enthaltener WertIm Artikel enthaltene Werte
    Baudax Bio Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Seite 3 MALVERN, Pa., July 03, 2020 (GLOBE NEWSWIRE) - Baudax Bio, Inc. (Nasdaq: BXRX), a pharmaceutical company focused on therapeutics for acute care settings, today announced that the Compensation Committee of Baudax Bio’s Board of Directors approved …